Home Air Quality Impact for Adults With Asthma

Sponsor
University of Kansas Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05224076
Collaborator
National Institute of Environmental Health Sciences (NIEHS) (NIH)
50
1
18.1
2.8

Study Details

Study Description

Brief Summary

The purposes of this study are to determine the practicality of using home indoor air quality monitoring and a smartphone app to identify home air quality changes and how these changes affect adults with asthma.

Condition or Disease Intervention/Treatment Phase
  • Other: Home Air Quality

Detailed Description

The aims of this feasibility study are: 1) determine the feasibility and usability of: (a) ecological momentary assessment (EMA) to assess self-report residential environmental exposures and asthma symptoms, (b) home monitoring of objective environmental exposures (total volatile organic compounds [VOCs], particulates [PM2.5]), and lung function (home spirometry); 2a) assess the frequency and degree of residential environmental exposures (e.g., disinfectants/cleaners, second-hand smoke) via (a) self-reported data, and (b) home monitoring objective measures, 2b) assess the level of asthma control as indicated by self-reported asthma symptoms and lung function; and 3) explore associations of self-reported and objective measures of residential environmental exposures with self-reported and objective measures of asthma control. Participants will receive an indoor air quality monitor and a home spirometer to measure VOCs, PM2.5, and forced expiratory volume percent predicted, respectively. EMA will be collected using a personal smartphone and EMA software platform. Participants' will be sent scheduled and random EMA notifications to assess asthma symptoms, environmental exposures, lung function, and mitigation strategies. After the 14-day data collection period, participants will respond to survey items related acceptability, appropriateness, and feasibility.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Symptoms in Adults
Actual Study Start Date :
Mar 30, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Home environmental exposure to Volatile organic compounds [Measured continuously for 14 days]

    Degree of home exposures to volatile organic compounds as measured by the Awair home air quality monitor

  2. Home environmental exposure to particulate matter (PM) [Measured continuously for 14 days]

    Degree of home exposures to PM2.5 as measured by the Awair home air quality monitor

  3. Asthma control [Assessed daily for 14 days]

    Forced Expiratory Volume (FEV) Percent predicted as measured by ZEPHYRx home spirometer

Secondary Outcome Measures

  1. Usability of study tools [14 days]

    Adapted System Usability Scale, 30 items assessing usability of the ZEPHYRx home spirometer, Awair home air quality monitor, and the EMA - with response options of 1= Strongly agree to 5=Strongly Disagree

  2. Compliance with Ecological Momentary Assessment (EMA) prompts [Compliance over 4-hour periods for 14 days]

    Frequency of responses to daily scheduled, random, and air quality triggered EMA prompts

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults who previously participated in the online Global Covid-19 and Asthma Study, indicated willingness to be contacted for future research, and reported high use of disinfectant/cleaning products since COVID-19 (≥5 per week).

  • Current Asthma Control Test (ACT) ≤19

  • Own a smartphone

  • Have a Wi-Fi/wireless internet connection in their home.

Exclusion Criteria:
  • Non-US residents

  • Non-English speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Barbara J Polivka Kansas City Kansas United States 66160

Sponsors and Collaborators

  • University of Kansas Medical Center
  • National Institute of Environmental Health Sciences (NIEHS)

Investigators

  • Principal Investigator: Barbara Polivka, PhD, Select

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT05224076
Other Study ID Numbers:
  • STUDY00145830
  • R21ES033118
First Posted:
Feb 4, 2022
Last Update Posted:
Jul 11, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Kansas Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2022